Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
10.20
+0.07 (0.69%)
Jan 29, 2026, 1:17 PM EST - Market open
Erasca Market Cap
Erasca has a market cap or net worth of $3.16 billion as of January 29, 2026. Its market cap has increased by 419.49% in one year.
Market Cap
3.16B
Enterprise Value
2.82B
1-Year Change
419.49%
Ranking
Category
Stock Price
$10.20
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $3.16B, an increase of 69.93%. That is a compound annual growth rate of 12.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 3.14B | 197.15% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 3.51B |
| Viking Therapeutics | 3.46B |
| Denali Therapeutics | 3.32B |
| Legend Biotech | 3.32B |
| Xenon Pharmaceuticals | 3.25B |
| Viridian Therapeutics | 3.22B |
| Vera Therapeutics | 3.20B |
| Arcutis Biotherapeutics | 3.10B |